Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137


Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL.

Huang JH, Zhang SN, Choi KJ, Choi IK, Kim JH, Lee MG, Kim H, Yun CO.

Mol Ther. 2010 Feb;18(2):264-74. doi: 10.1038/mt.2009.205. Epub 2009 Sep 8. Erratum in: Mol Ther. 2010 Feb;18(2):449. Lee, Mingul [corrected to Lee, Min-Geol].


Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF.

Zhang SN, Choi IK, Huang JH, Yoo JY, Choi KJ, Yun CO.

Mol Ther. 2011 Aug;19(8):1558-68. doi: 10.1038/mt.2011.29. Epub 2011 Apr 5.


Construction of a recombinant adenovirus co-expressing truncated human prostate-specific membrane antigen and mouse 4-1BBL genes and its effect on dendritic cells.

Weng X, Kuang Y, Liu X, Chen Z, Zhu H, Chen H, Jiang B, Shen H.

Braz J Med Biol Res. 2011 Mar;44(3):186-92. Epub 2011 Jan 14.


The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma.

Xu DP, Sauter BV, Huang TG, Meseck M, Woo SL, Chen SH.

Gene Ther. 2005 Oct;12(20):1526-33.


Anti-prostate cancer effects of CTL cell induction in vitro by recombinant adenovirus mediated PSMA/4-1BBL dendritic cells: an immunotherapy study.

Sui CG, Wu D, Meng FD, Yang MH, Jiang YH.

Genet Mol Res. 2015 Jun 29;14(2):7208-17. doi: 10.4238/2015.June.29.14.


Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF.

Choi KJ, Zhang SN, Choi IK, Kim JS, Yun CO.

Gene Ther. 2012 Jul;19(7):711-23. doi: 10.1038/gt.2011.125. Epub 2011 Oct 13.


Anti-tumor immune response induced by dendritic cells transduced with truncated PSMA IRES 4-1BBL recombinant adenoviruses.

Kuang Y, Weng X, Liu X, Zhu H, Chen Z, Jiang B, Chen H.

Cancer Lett. 2010 Jul 28;293(2):254-62. doi: 10.1016/j.canlet.2010.01.011. Epub 2010 Feb 9.


Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα.

Choi IK, Lee JS, Zhang SN, Park J, Sonn CH, Lee KM, Yun CO.

Gene Ther. 2011 Sep;18(9):898-909. doi: 10.1038/gt.2011.37. Epub 2011 Mar 31. Erratum in: Gene Ther.2011 Sep;18(9):942.


Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.

Lee YS, Kim JH, Choi KJ, Choi IK, Kim H, Cho S, Cho BC, Yun CO.

Clin Cancer Res. 2006 Oct 1;12(19):5859-68.


Enhanced function of cytotoxic T lymphocytes induced by dendritic cells modified with truncated PSMA and 4-1BBL.

Youlin K, Li Z, Xin G, Mingchao X, Xiuheng L, Xiaodong W.

Hum Vaccin Immunother. 2013 Apr;9(4):766-72. doi: 10.4161/hv.23116. Epub 2013 Jan 7.


Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.

Choi KJ, Kim JH, Lee YS, Kim J, Suh BS, Kim H, Cho S, Sohn JH, Kim GE, Yun CO.

Gene Ther. 2006 Jul;13(13):1010-20. Epub 2006 Mar 9.


Combined therapy with cytokine-induced killer cells and oncolytic adenovirus expressing IL-12 induce enhanced antitumor activity in liver tumor model.

Yang Z, Zhang Q, Xu K, Shan J, Shen J, Liu L, Xu Y, Xia F, Bie P, Zhang X, Cui Y, Bian XW, Qian C.

PLoS One. 2012;7(9):e44802. doi: 10.1371/journal.pone.0044802. Epub 2012 Sep 18.


Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: long- term remission of liver metastases in a mouse model.

Martinet O, Ermekova V, Qiao JQ, Sauter B, Mandeli J, Chen L, Chen SH.

J Natl Cancer Inst. 2000 Jun 7;92(11):931-6.


The change of immunoactivity of dendritic cells induced by mouse 4-1BBL recombinant adenovirus.

Youlin K, Xiaodong W, Xiuheng L, Zhiyuan C, Hengcheng Z, Hui C, Botao J.

Yonsei Med J. 2010 Jul;51(4):594-8. doi: 10.3349/ymj.2010.51.4.594.


Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-γ- and TNF-α-co-producing T cell-mediated antitumor immunity.

Choi IK, Li Y, Oh E, Kim J, Yun CO.

PLoS One. 2013 Jul 3;8(7):e67512. doi: 10.1371/journal.pone.0067512. Print 2013.


Long-term proliferation of functional human NK cells, with conversion of CD56(dim) NK cells to a CD56 (bright) phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12.

Dowell AC, Oldham KA, Bhatt RI, Lee SP, Searle PF.

Cancer Immunol Immunother. 2012 May;61(5):615-28. doi: 10.1007/s00262-011-1122-3. Epub 2011 Oct 22.


Potent anti-prostate cancer immune response induced by dendritic cells transduced with recombinant adenoviruses encoding 4-1BBL combined with cytokine-induced killer cells.

Youlin K, Jian K, Siming L, Li Z, Weiyang H, Chaodong L, Xin G.

Immunotherapy. 2015;7(1):13-20. doi: 10.2217/imt.14.92.


Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunity.

Lapteva N, Aldrich M, Weksberg D, Rollins L, Goltsova T, Chen SY, Huang XF.

J Immunother. 2009 Feb-Mar;32(2):145-56. doi: 10.1097/CJI.0b013e318193d31e.


A novel adenovirus expressing human 4-1BB ligand enhances antitumor immunity.

Yoshida H, Katayose Y, Unno M, Suzuki M, Kodama H, Takemura S, Asano R, Hayashi H, Yamamoto K, Matsuno S, Kudo T.

Cancer Immunol Immunother. 2003 Feb;52(2):97-106. Epub 2003 Jan 18.


[Prostate cancer cell vaccine transfected with 4-1BBL induces anti-tumor immunity in vitro].

Kuang YL, Weng XD, Liu XH, Chen ZY, Zhu HC, Jiang BT.

Zhonghua Nan Ke Xue. 2010 Sep;16(9):773-7. Chinese.

Items per page

Supplemental Content

Write to the Help Desk